Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported 81K in Gross Profit on Sales for its fiscal quarter ending in December of 2023.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Actinium Pharmaceuticals 81K 36K Dec/2023
Amgen USD 6.48B 307M Sep/2025
Bioline Rx USD 343K 111K Sep/2025
Capricor Therapeutics 11.13M 8.87M Dec/2024
Pfizer USD 3.54B 7.61B Sep/2025